Renal Cancer - Results from #1840

Clinical Outcomes and Adverse Events after First-Line Treatment in Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-Analysis. September 23, 2021

External validation of the REMARCC model for the selection of cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma: A multicenter retrospective study. September 23, 2021

The blood metabolome of incident kidney cancer: A case-control study nested within the MetKid consortium. September 22, 2021

Interpreting nephrometry scores with three-dimensional virtual modelling for better planning of robotic partial nephrectomy and predicting complications. September 21, 2021

Dynamic contrast-enhanced CT-derived blood flow measurements enable early prediction of long term outcome in metastatic renal cell cancer patients on antiangiogenic treatment. September 21, 2021

Treatment Options for De Novo Metastatic Clear-cell Renal Cell Carcinoma: Current Recommendations and Future Insights. September 20, 2021

CT and MRI findings of cystic renal cell carcinoma: comparison with cystic collecting duct carcinoma. September 17, 2021

Biomarker Screening and Prognostic Significance Analysis for Renal Cell Carcinoma. September 17, 2021

Sequential immune-targeted surgical therapy resulted in disease-free survival in a case with advanced renal cell carcinoma. September 16, 2021

Renal Tumor Biopsy: Rationale to Avoid Surgery in Small Renal Masses. September 16, 2021

Conditional survival of metastatic clear cell renal cell carcinoma: How prognosis evolves after cytoreductive surgery of primary tumor. September 15, 2021

The prognosis and clinicopathological features of different distant metastases patterns in renal cell carcinoma: analysis based on the SEER database. September 14, 2021

Integrated mRNA and miRNA Transcriptomic Analyses Reveals Divergent Mechanisms of Sunitinib Resistance in Clear Cell Renal Cell Carcinoma (ccRCC). September 14, 2021

A statewide quality improvement collaborative's adherence to the 2017 AUA guidelines regarding initial evaluation of patients with cT1 renal masses. September 13, 2021

p53 is functionally inhibited in clear cell renal cell carcinoma (ccRCC): a mechanistic and correlative investigation into genetic and molecular characteristics. September 13, 2021

The Association of Controlling Nutritional Status (CONUT) Score with Survival in Patients with Surgically Treated Renal Cell Carcinoma and Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis. September 10, 2021

Antioxidant Gene Signature Impacts the Immune Infiltration and Predicts the Prognosis of Kidney Renal Clear Cell Carcinoma. September 10, 2021

Influence of histologic types and subtypes on survival outcomes of intermediate-high and high-risk renal cell carcinoma following nephrectomy: Findings from the SEER database. September 9, 2021

Tumor-infiltrating CD8+ T cells recognize a heterogeneously expressed functional neoantigen in clear cell renal cell carcinoma. September 9, 2021

Immune-related adverse events and kidney function decline in patients with genitourinary cancers treated with immune checkpoint inhibitors. September 8, 2021

Page 93 of 456